MAO B selective inhibitor was given to parkinsonism patients for several months. Positive effect was found in half of the patients irrespective of their age, time of the disease onset and its severity. The drug proved most effective in bradykinesia. Its use is most expedient in combination with L-DOPA-containing drugs which prolong the effect and reduced diurnal shifts in the patients' conditions. Side effects are seldom observed and usually weak.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[experience selective
4
selective monoamine
4
monoamine oxidase
4
oxidase inhibitors
4
inhibitors treating
4
treating parkinsonism
4
parkinsonism patients]
4
patients] mao
4
mao selective
4
selective inhibitor
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!